Alan Tong
Family · San Jose, CANPI 1770215154
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 604 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 604 payments — averaging $27.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$2K
- Johnson & Johnson$2K
- Lilly USA, LLC$1K
- Incyte Corporation$980
- plus $6K from 22 others
What the payments were for
- Food & beverage$15,28994%
- Education$1,0226%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 103 | $2,651 |
| Regeneron Healthcare Solutions, Inc. | 77 | $2,210 |
| Sanofi | 58 | $1,945 |
| Johnson & Johnson | 64 | $1,642 |
| Lilly USA, LLC | 41 | $1,229 |
| Incyte Corporation | 40 | $980 |
| Novartis | 58 | $946 |
| Galderma Laboratories, L.p. | 30 | $767 |
| E.r. Squibb & Sons, L.L.C. | 25 | $746 |
| Sun Pharmaceutical Industries Inc. | 20 | $633 |
| Arcutis Biotherapeutics, Inc. | 14 | $484 |
| Pfizer | 21 | $439 |
| UCB, Inc. | 7 | $295 |
| Organon | 10 | $250 |
| Dermavant Sciences, Inc. | 8 | $184 |
| LEO Pharma Inc. | 6 | $169 |
| Amgen | 2 | $155 |
| Janssen Scientific Affairs, LLC | 1 | $149 |
| Merz North America, Inc. | 4 | $113 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $96 |
| Genentech USA, Inc. | 3 | $69 |
| Almirall LLC | 1 | $32 |
| Boehringer Ingelheim | 1 | $31 |
| Cipher Pharmaceuticals US LLC | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Icad, Inc | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $19 |
| Nobelpharma America, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,311 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 41 | $152,554 |
| Tacrolimus | 34 | $5,935 |
| Calcipotriene | 26 | $5,378 |
| Ketoconazole | 233 | $4,070 |
| Metronidazole | 46 | $2,465 |
| Clindamycin Phosphate | 47 | $2,336 |
| Fluocinonide | 49 | $2,315 |
| Mometasone Furoate | 124 | $2,245 |
| Doxycycline Monohydrate | 73 | $1,177 |
| Ciclopirox | 70 | $1,128 |
| Clobetasol Propionate | 25 | $876 |
| Triamcinolone Acetonide | 93 | $571 |
| Imiquimod | 16 | $437 |
| Hydrocortisone | 67 | $291 |
| Nystatin | 18 | $275 |
Paid to pharmacies, not to this prescriber.
Other family in San Jose
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.